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The arterial vessel wall is composed of a single layer of
endothelial cells at the lumen and multiple layers of smooth
muscle cells (SMC) forming the media and then the adventi-
tia. The primary function of the medial SMC is to provide the
elastic and contractile properties to maintain vascular tone
but they can also undergo phenotypic change, as occurs in
response to vascular injury and in diseases such as atheroscle-
rosis, to a phenotype where they proliferate, migrate and syn-
thesise more extracellular matrix [1,2]. This phenotypic mod-
ulation from the mature ‘contractile’ state to a less
di¡erentiated ‘synthetic’ state is associated with a loss of cy-
toplasmic myo¢laments and changes in gene expression par-
ticularly those encoding cytoskeletal proteins [2,3]. Various
workers have identi¢ed genes induced in animal models of
arterial injury such as the balloon de-endothelialised carotid
artery [4] and others have isolated markers of di¡erentiated or
proliferating SMC by di¡erential cDNA screening in vitro
and identi¢ed gene products associated with contractile func-
tion or with the extracellular matrix [1]. We have used a
primary culture model where the process of SMC phenotypic
change occurs spontaneously, without induction with a spe-
ci¢c factor, when SMC freshly isolated from the artery wall
are plated at less than con£uent density [2]. Standard di¡er-
ential display techniques [4] have enabled us to identify genes
which show altered expression as cells undergo the process of
phenotypic modulation in this primary culture system.
Cultures of SMC were established from thoracic and ab-
dominal aortae of 9^12-week-old rabbits with collagenase and
elastase and seeded at sub-con£uent density. RNA was ex-
tracted from primary cultures using the standard acid guani-
dinium thiocyanate/phenol chloroform extraction method, as
they started to de-di¡erentiate (day 2) and when the change to
the de-di¡erentiated phenotype was almost complete (day 4).
cDNA was synthesised from the extracted RNA from SMC at
these two time points and ampli¢ed by PCR using degenerate
oligo(dT) primers and arbitrary decamer primers annealed at
random positions upstream of the poly(A) tail. Analysis of
cDNA fragments on a 6% polyacrylamide sequencing gel
showed at least 10 bands di¡erentially expressed. Of the three
bands that showed most marked di¡erential expression two
transcripts were highly expressed at day 2 while the third
transcript showed a marked up-regulation at day 4. These
fragments were excised from the gel, re-ampli¢ed and cloned
and sequenced. Analysis of the sequence of these transcripts
showed that the ¢rst transcript (accession number AF399638)
had 84.2% identity with human tropomyosin-1 (TM-L, acces-
sion number M74817), in a 317-bp overlap. The second tran-
script (accession number AF438159) showed very high homol-
ogy with human heparan sulphate N-deacetylase/N-
sulfotransferase (NDST, accession number U18918) with
91.2% identity in a 341-bp overlap, and the third transcript
(accession number AF408849) had 86.2% identity with the
human ribosomal protein gene, rpL17 (accession number
T58361), in a 174-bp overlap. In all three cases the homology
was at or near the 3P end of the mRNA. These homologies
were con¢rmed using full-length cDNA clones of rabbit L-
tropomyosin (91.7% identity to human TM-L) and rabbit ri-
bosomal protein rpL17 (88.2% identity to human rpL17) ob-
tained from a rabbit SMC cDNA library prepared in our
laboratory from aortic SMC in culture. RT-PCR performed
with speci¢c primers for these transcripts using cDNA synthe-
sised from the RNA extracted from SMC primary culture at
day 2 and 4 con¢rmed the di¡erential expression of these
transcripts (Fig. 1a).
Antibodies against NDST and tropomyosin allowed us to
assess the relevance of these ¢ndings by examining the expres-
sion of these proteins in vivo after balloon catheter de-endo-
thelialisation injury to the rabbit aorta [5]. Immunoblotting of
protein extracts with the tropomyosin antibody showed the
presence of two bands at approximately 39 kDa and 36
kDa (Fig. 1b), which likely correspond to smooth muscle L
(TM-1) and K isoforms respectively. Higher expression of the
39-kDa isoform than the 36-kDa isoform was observed with
some decrease at 7 days after injury. The 36-kDa isoform
showed more variation with lower levels most evident at
1 and 7 days after injury. The NDST protein band (at the
expected size of 97 kDa) was highly expressed in normal
(uninjured) artery, and also showed lower levels at 1 and
7 days after injury (Fig. 1b). We have shown previously a
change in SMC phenotype quantitated by a decrease in vol-
ume fraction of myo¢laments within the same time frames by
cells both in vitro [2] and in vivo following arterial injury [5].
Decreased overall levels of tropomyosin along with other
cytoskeletal proteins have previously been suggested in SMC
of a more ‘synthetic phenotype’ [3]. Two main tropomyosin
isoforms are expressed in smooth muscle, identi¢ed as TM-1
or smooth muscle L and smooth muscle K, which are thought
to play a role in stabilisation of actin ¢laments in this cell
type. Down-regulation of TM-L tropomyosin expression has
been reported in dedi¡erentiating chicken gizzard and vascu-
lar SMC in culture, while smooth muscle TM-K converted to
TM-F1-K and TM-F2-K [3]. Our results for TM-L mRNA
suggest a similar trend, with expression high at day 2 of pri-
mary culture but decreased to very low levels at day 4. In
addition our in vivo observations point to varied regulation
of the TM-K and -L isoforms with some increase in TM-L up
to day 3 followed by a decrease. This suggests for the ¢rst
time, in both the injured artery and primary culture models,
that expression of this tropomyosin isoform is transiently up-
regulated as SMC begin the process of phenotypic modula-
tion, as well as being decreased to low levels once cells have
modulated to the ‘synthetic’ phenotype.
Our previous work has suggested that there is a constant
turnover of heparan sulphate in contractile SMC and that this
turnover (synthesis and degradation) may be essential for
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maintenance of normal phenotype [5]. Certainly the normal
‘contractile’ cell phenotype can be maintained in vitro by the
addition of heparin or heparan sulphate and the addition of
heparanase results in a change towards the synthetic pheno-
type. Addition of arterial heparan sulphate to injured arteries
also inhibits the development of neointimal thickening after
arterial injury. Thus it is not surprising that NDST, a key
enzyme of heparan sulphate synthesis, may also be part of
the process of change in cell phenotype. Our results show
that NDST is expressed by most cells in the normal artery
wall indicating constant turnover of heparan sulphate, but its
expression is rapidly down-regulated after arterial injury. In-
deed it is possible that change in the sulphated epitope of
heparan sulphate around SMC, by change in the levels of
NDST, may be just as important as decreased overall levels
of heparan sulphate since it is known that changes in sulph-
ated domains are critical to functional interaction of heparan
sulphate in other systems.
The up-regulation of rpL17 expression by SMC at day 4 in
primary culture suggests a role for ribosomal up-regulation in
the latter phase of the process of SMC modulation from a
di¡erentiated ‘contractile’ to a less di¡erentiated ‘synthetic’
phenotype in which the cells synthesise much more protein
and proliferate in response to mitogens. A recent di¡erential
display study of genes expressed 7 days after injury to the rat
carotid artery showed increased expression of a ribosomal
phosphoprotein [4], consistent with this premise. The levels
of mRNA for ribosomal proteins appear to be coordinately
regulated and depend on the cell’s need for protein biosyn-
thetic capacity. Changes in the state of cellular di¡erentiation
or de-di¡erentiation will lead to a decrease or increase in
protein synthesis in the ribosome such that ribosomal proteins
are generally decreased with cell di¡erentiation and increased
with cell de-di¡erentiation. For example a number of riboso-
mal protein genes are down-regulated during di¡erentiation
and up-regulated during de-di¡erentiation of myoblasts and
ribosomal protein genes are up-regulated in tumours and cell
lines. Thus expression of rpL17 in our system is consistent
with increased protein synthesis as cells modulate their phe-
notype.
In summary, we have identi¢ed three genes di¡erentially
expressed in primary culture of vascular SMC that are asso-
ciated with the process of change in SMC phenotype seen
under these conditions and corresponding changes in vivo
after vascular injury. Since a similar change in phenotype is
seen in vascular diseases such as atherosclerosis [1,2], these
genes may play a role in vascular pathology.
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Fig. 1. a: RT-PCR of transcripts at day 2 versus day 4 of SMC culture using speci¢c primers from the sequence analysis of the clones. Lanes
1 and 8 are molecular weight markers (Bluescript digested with HpaII). Lanes 2 and 3 are tropomyosin at day 2 and day 4 SMC culture re-
spectively (using speci¢c forward primer 5P-GACTCAGACCGCAAATAC-3P, and reverse primer 5P-TGAAATCTCCACGTTCTC-3P) ; lanes 4
and 5 are rpL17 at day 2 and day 4 (forward primer, 5P-TCAAGATGTCGAAGCGAGG-3P and reverse primer, 5P-GGAGAATCATG-
CAATGCTG-3P); and lanes 6 and 7 are NDST at day 2 and day 4 (forward primer, 5P-TATCCACTCCATCCTCAAG-3P and reverse primer,
5P-AGGGTATAAACTCTGGCAC-3P). RT-PCR-ampli¢ed fragments (707 bp) of the rabbit GAPDH gene cloned in our laboratory are shown
as controls (forward primer, 5P-CTTCACCACCATGGAGAAGG-3P and reverse primer, 5P-CTTACTCCTTGGAGGCCAT-3P) using the same
RNA samples at day 2 and 4. b: Western blot analysis of tropomyosin (antibody TM311; Sigma) and NDST (polyclonal antibody generated
against a human NDST peptide; gift from Dr J Stow, University of Queensland) expression in vivo. Lane 1 is normal artery extract; lanes 2^6
are artery extract at 6 h, 1 day, 3 days, 5 days, and 7 days after injury. Two bands of tropomyosin expression are seen at 39 and 36 kDa.
NDST is seen as a 97-kDa band.
FEBS 25557 5-12-01
A.A. Girjes et al./FEBS Letters 509 (2001) 341^342342
